Bruce Given

Chief Medical Scientist, Arrowhead Pharmaceutical

Search every verified Bruce Given interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Bruce Given, Chief Medical Scientist at Arrowhead Pharmaceutical, was referenced in a September 2020 interview with CEO Christopher Anzalone on CNBC's Mad Money. During the interview, Anzalone discussed the company's partnerships with Johnson & Johnson and Amgen, describing them as arrangements where Arrowhead develops drugs and the partners handle clinical trials and commercialization in exchange for milestone payments and royalties. Anzalone also stated that Arrowhead's RNA interference technology had been used to silence genes in over 110 people across 160 doses without any serious adverse events, and that the company was working to expand the technology beyond the liver and to target multiple genes simultaneously.